The Mine Safety and Health Administration (MSHA) is proposing to cut in half the exposure limit for coal dust, the cause of black lung disease. MSHA estimates the new standard will prevent thousands of illnesses and hundreds of deaths over the lifetimes of miners.
“The proposed rule would lower the existing concentration limits for respirable coal mine dust from 2 milligrams of dust per cubic meter of air, or 2 mg/m³, to 1 mg/m³ over a 24-month phase-in period,” MSHA said yesterday. The 1mg/m3 standard is consistent with recommendations made by a Department of Labor advisory committee and by the National Institute for Occupational Safety and Health (NIOSH), both from the 1990s.
MSHA is also proposing to change the way coal dust is monitored. According to former MSHA official and mine safety expert Celeste Monforton, the proposed rule would “change the way miners' exposure to coal dust is measured from an average over five shifts to a single, full-shift sample (consistent with standard industrial hygiene practice) and monitor of coal dust levels based on typical production levels in the mine.”
Prolonged exposure to coal dust can cause coal workers' pneumoconiosis (CWP), commonly referred to as black lung, which leads to serious pulmonary problems and, in the worst cases, death. Although long recognized as a serious but preventable risk, incidents of black lung are actually on the rise, according to NIOSH.
The preamble to the proposed rule says that the changes would prevent more than 2,800 cases of CWP, almost 800 cases of progressive massive fibrosis (a progressive form of CWP), almost 700 cases of severe emphysema, and 131 deaths from non-malignant respiratory disease, all over a 45-year work life.
MSHA has proposed new standards for black lung in the past but failed to finalize them. “During the Clinton and the GW Bush Administration, MSHA proposed rules addressing these same problems, but they were never issued as a final rules,” Monforton said. “I'm hopeful this third time will be the charm.”
MSHA is developing the standard as a part of its “End Black Lung – Act Now!” initiative, the goal of which is to eliminate black lung disease. MSHA will publish a notice of proposed rulemaking in the Federal Register on Oct. 19 (until then, it’s available here) and accept public comments on the standard until Dec. 18.
(Matthew Madia 10/15/10; 1 comment)A new analysis by the Environmental Working Group (EWG) suggests that many Americans are at risk of exposure to a dangerous chemical that has been found in baby bottles, the lining of food and beverage containers, and now paper receipts. Significant levels of bisphenol-A (BPA), a controversial chemical that is not currently regulated by the Food and Drug Administration or the Environmental Protection Agency, was found in 40 percent of paper receipts collected from major retailers, grocery stores, convenience stores, gas stations, fast-food restaurants, post offices and ATMs.
Exposure to BPA has been linked to developmental disorder, cancer, heart diseases, and other health problems. The Centers for Disease Control and Prevention found that nearly all Americans have some level of BPA in their bodies. The recent finding that there are high levels of BPA in receipts from stores that most Americans visit regularly could provide an insight as to why exposure is so widespread. BPA is already known to leach into food and beverage products through packaging, but EWG’s study found that BPA can easily rub off paper receipts onto hands and food. The Washington Post spoke with Sonya Lunder, a senior analyst with EWG:
"We've come across potentially major sources of BPA right here in our daily lives," Lunder said. "When you're carrying around a receipt in your wallet for months while you intend to return something, you could be shedding BPA into your home, into your environment. If you throw a receipt into a bag of food, and it's lying there against an apple, or you shove a receipt into your bag next to a baby pacifier, you could be getting all kinds of exposure and not realize it."
So why is BPA flying under the radar of the agencies that have been entrusted to protect public health? In January, FDA announced the results of a scientific evaluation of BPA and found that there is “reason for some concern about the potential effects of BPA on the brain, behavior, and prostate gland of fetuses, infants and children.” But instead of laying out a regulatory path for protecting consumers from exposure to BPA, FDA merely stated that it “recognizes substantial uncertainties with respect to the overall interpretation of these studies and their potential implications for human health effects of BPA exposure.”
Many consumer advocacy groups found this non-conclusion unsatisfactory, and on June 28, Natural Resources Defense Council (NRDC) sued FDA in an effort to force the agency to set safety standards for BPA in food. On March 29, EPA announced that it would add BPA to its list of “chemicals of concern,” pledging to look more closely at BPA’s potential health impacts. While both these developments provide some hope that BPA will soon be regulated on a federal level, many state and local governments have taken public safety into their own hands through legislative bans on the chemical.
(Rachel Sauter* 07/28/10; 3 comments)The Natural Resources Defense Council (NRDC) is suing the Food and Drug Administration with the hopes of forcing the agency to regulate bisphenol-A (BPA), a chemical commonly found in hard plastics (like reusable water and baby bottles), the lining of food and beverage containers, and other everyday products. Exposure to BPA has been linked to developmental disorder, cancer, heart diseases, and other health problems.
In October 2008, NRDC petitioned the FDA to set safety standards for bisphenol-A in food. “In light of the data suggesting that BPA is harmful to human health, and in response to the well-founded concerns of experts in the field, FDA must prohibit BPA from use in human food and food packaging, including in can linings and in beverage containers like baby bottles,” the petition says. Under the Federal Food, Drug, and Cosmetic Act, FDA had 90 days to grant the petition and begin a rulemaking, deny the petition, or ask for an extension of the 90-day time limit.
Instead, FDA did nothing. Nil, nada, squadoosh. So, on June 29, NRDC filed suit in the D.C. Circuit Court of Appeals asking the court to order FDA to respond to the petition.
“Our patience has run out,” NRDC scientist Sarah Jannsen wrote on the group’s website. “Most people assume that the government wouldn’t allow Americans to be exposed to BPA if it wasn’t safe, but while the FDA has been reviewing the science, as of yet, no action has been taken.”
Meanwhile, states continue to act in the absence of federal regulation. California’s state assembly moved the nation’s largest state one step closer to banning BPA in baby bottles and other products intended for infants and small children when it passed on July 1 the Toxics-Free Babies and Toddlers Act. The bill now moves to the state senate, where similar legislation has already passed.
“If passed, [the bill] would require the manufacturers of baby bottles, cups and jars to discontinue use of BPA by January 2012,” according to the Los Angeles Times. “Makers of infant formula would need to comply by July 2012.”
In January, FDA announced the results of a scientific evaluation of BPA and declared that it has “some concern” about the chemical’s health effects. However, the agency stopped short of outlining a regulatory path to limit consumer exposure to BPA.
(Matthew Madia 07/02/10; 0 comments)On Monday, the Environmental Protection Agency (EPA) unveiled an action plan for addressing bisphenol-A (BPA), a common chemical found in a variety of hard plastics and the lining of food can containers.
Among other things, the agency said it would add BPA to its list of “chemicals of concern,” look more closely at BPA’s presence in the environment, and require manufacturers submit information on health impacts.
Studies have linked BPA exposure to heart disease, developmental disorders, and other health problems. Environmental and consumer advocates have for years been pushing regulators to set standards for BPA’s use and exposure but, so far, none exist.
EPA looks to be pacing the Food and Drug Administration (FDA) which in January announced that it had “some concern” about BPA but would not regulate the substance. Like FDA, EPA’s plan takes positive rhetorical steps, but pledges little in the way of action.
Still, EPA’s willingness to put BPA on its agenda, and its multi-pronged approach to assessing exposure pathways and health effects, is a good sign. Here is a bit of the release from the Environmental Working Group, an active advocate for BPA awareness and regulation:
“BPA is now under investigation at both the FDA and the EPA,” said Environmental Working Group’s Richard Wiles, EWG’s co-founder and Senior VP for Policy and Communications. “It’s a clear indication that this notorious and ubiquitous toxic chemical, found in virtually everyone’s body, has top officials in the Obama administration concerned.”(Matthew Madia 03/31/10; 0 comments)
On Friday, the Food and Drug Administration made its long-awaited announcement on the safety of bisphenol-A, a chemical ingredient in hard plastics, food can liners, and other common products. The verdict? “[R]ecent studies provide reason for some concern about the potential effects of BPA on the brain, behavior, and prostate gland of fetuses, infants and children. FDA also recognizes substantial uncertainties with respect to the overall interpretation of these studies and their potential implications for human health effects of BPA exposure.”
While it’s good to hear FDA finally admit that BPA could be a health threat, its plan going forward lacks the aggressiveness many were expecting. Instead of announcing a regulatory path to limit consumer exposure to BPA, FDA reiterated warnings that parents throw away their children’s hard plastic baby bottles or cups if they are scratched and that that consumers avoid putting hot liquids in BPA containers.
Urvashi Rangan of Consumers Union hit the nail on the head when he called FDA’s message “confusing.” How can the agency say that something as seemingly-benign as a scratched bottle poses a potential threat, but not take precautionary steps? Food Safety News reports:
Dr. Rangan believes there is ample evidence for the government to regulate the chemical in food containers. "FDA's admission of concern with BPA is an encouraging change in its position and we hope it will lead to concrete protection for consumers. However, we are concerned that the new advice on reducing exposure puts the onus on consumers to protect themselves until such a ban is put in place."
Consumers have lived too long under a cloud of uncertainty: while the federal government has sat on the sidelines, state and local governments have taken action, and manufacturers and retailers have taken BPA-laden products off store shelves.
At the same time, the Milwaukee Journal Sentinel has an interesting story that evokes some sympathy for the FDA. Apparently, officials at the agency feel hamstrung by their own regulatory framework:
FDA officials - including Sharfstein; Lynn Goldmann, a consultant to the FDA; and Jesse Goodman, the FDA's acting chief scientist - told the Journal Sentinel they were frustrated by the antiquated framework of the FDA's regulatory process.
Officials say they would like chemical manufacturers to report information about the chemical to them, including how much BPA they produce and where and how it is used.
But because BPA was classified years ago as an indirect food additive, it is not subject to the kind of scrutiny that other chemicals are. Without critical data about BPA, it is impossible to regulate the chemical, officials said.
Sharfstein told the paper, "We may have to go after legislation to change it.”
(Matthew Madia 01/19/10; 1 comment)In another of The New York Times’ startling articles on the state of U.S. waters, Charles Duhigg reports on the myriad chemicals polluting drinking water supplies and regulators’ inability to manage them.
The whole article is worth reading for its insights into public health, public policy, and even public relations. On the regulatory front, it seems like it boils down to essentially two problems.
First, for contaminants for which drinking water standards do exist, the standards are too high. “For instance, the drinking water standard for arsenic, a naturally occurring chemical used in semiconductor manufacturing and treated wood, is at a level where a community could drink perfectly legal water, and roughly one in every 600 residents would likely develop bladder cancer over their lifetimes, according to studies commissioned by the E.P.A. and analyzed by The Times.”
Second, too many contaminants are completely unregulated – and the more time that passes without regulation, the longer the queue grows, as new chemicals enter into commerce.
The Times article examines the Safe Water Drinking Act and EPA’s enforcement of it. A major component of EPA’s implementation of the Act is the contaminant candidate list, a catalog of chemicals “that are currently not subject to any proposed or promulgated national primary drinking water regulations, that are known or anticipated to occur in public water systems, and which may require regulation,” according to the EPA. The list is to be updated every 5 years.
The good news is that In October EPA updated the list which now includes 116 contaminants, up from 51 in 2005, according to EPA’s website. (The ’05 update was late.) Recognizing the growing concern over hormone-imitating compounds in the water supply, EPA added to the final candidate list nine hormones that weren’t on an earlier draft list, according to BNA news service (subscription).
The bad news is that EPA never follows through. In July 2003 and again in July 2008, EPA announced its final determination that no regulation was necessary for contaminants on the list. The next round of determinations – or lack thereof – is due by 2013.
(Matthew Madia 12/17/09; 32 comments)The Food and Drug Administration (FDA) missed a self-imposed deadline to make a determination about the safety of bisphenol-A (BPA), a chemical ingredient in hard plastics, food can liners, and other common products. Studies have linked BPA exposure to heart disease, developmental disorders, and other health problems.
A draft assessment on BPA released by FDA last year was widely criticized. In the draft assessment, FDA identified "margins of safety" for both infants and adults and contended, at levels most humans are exposed to, the margins are adequate. But the FDA’s own scientific advisory board later said the available evidence "provides a sufficient scientific basis to conclude that the Margins of Safety defined by FDA as 'adequate' are, in fact, inadequate."
In August, FDA said it would complete a review of the scientific information on BPA by the end of November. FDA now hopes to make a determination in the coming weeks. Meg Kissinger from the Milwaukee Journal Sentinel reports:
Michael Herndon, the FDA spokesman, urged patience.
"We are pushing hard for some decision soon," he said. "Too soon for anyone to be frustrated."
However, with state and local governments taking regulatory action on BPA and some manufacturers limiting it in their products, consumers will continue to be frustrated until the federal government takes a definitive stance on BPA’s health effects.
Photo by Flickr user davidfntau. Used under a Creative Commons license.
(Matthew Madia 12/01/09; 0 comments)White House Office of Management and Budget (OMB) Director Peter Orszag said Monday that OMB did not improperly interfere in an EPA program meant to test the hormone-disrupting effects of chemicals. Orszag said that EPA has complete control over the program.
In a letter to Rep. Edward Markey (responding to a letter Markey sent Oct. 22), Orszag said, “OMB does not question the scientific responsibilities and rigors put forward by the EPA.”
At issue is EPA’s Endocrine Disruptor Screening Program (EDSP) which requires pesticide and other chemical manufacturers to test their products for adverse effects on the human endocrine system. EPA has developed a battery of tests designed to detect endocrine disrupting effects at low doses, but OMB urged the agency to also consider existing studies – a.k.a. other scientifically relevant information, or OSRI – “to the greatest extent possible.” (Click here for more background.)
Some in the scientific community fear that existing studies are not tailored to determine the health effects of these chemicals and that, if those studies exonerate the chemicals in question, EPA will not be able to ultimately write regulations needed to protect against the effects low dose exposure – regulations that the pesticide industry fears.
The forceful tone of Orszag’s response is a good sign. In the letter, he seeks to assure Markey that science, not politics, is leading the way:
Science is the ultimate determinant of EPA’s actions in these processes. I share your belief that EPA must continue to have a robust endocrine testing program, and I reiterate that OMB fully supports the EPA’s sole authority to make the scientific decisions related to this effort.
Still, when it comes to implementation of the EDSP, nothing has really changed. We won’t be able to gauge the impact of OMB’s role until manufacturers submit their initial responses to EPA test orders. (The first round of deadlines are in February.) If industry submits existing studies in tandem with fresh data generated through the EPA-developed testing protocols, no big deal; but if industry is able to submit studies in lieu of new testing, using OMB’s past interjections as a cover, EPA may not get the data it needs to make critical decisions that protect the public from harmful substances.
(Matthew Madia 11/19/09; 1 comment)Researchers spent years studying the effects of bisphenol-A (BPA) exposure on factory workers in China, and the news isn't good. The key findings of the study, which was funded by the U.S. National Institute of Occupational Safety and Health, are more or less summed up in these two passages:
For more on the study, see this article from the Milwaukee Journal Sentinel.
BPA is an ingredient in hard, polycarbonate plastics. No. 7 plastics, like those used for reusable water bottles, are usually polycarbonate. Bisphenol-A is also an ingredient in certain resins used to line food cans.
Scads of studies have linked bisphenol-A exposure to heart disease, developmental disorders, and other health problems. But most of those studies used rodents to study the effects of BPA. The study of the Chinese workers is the first major study to look at human exposure.
BPA is ubiquitous, and as a result the exposure pathways are numerous. Environmental and occupational exposure in addition to food container and consumer product exposure put at least four federal regulatory agencies on the hook: the Environmental Protection Agency, Occupational Safety and Health Administration, Food and Drug Administration (FDA), and Consumer Product Safety Commission, respectively.
The study has this to say:
[T]he question of the adverse effect of exposure to BPA on human health has raised substantial concern among the public because of widespread presence of BPA in the environment and in consumer products such as baby bottles and food and water containers. Therefore, studies of the effect of BPA on humans are critically needed to help establish prevention strategies and regulatory policies.
The FDA has promised to update its opinion on BPA safety by the end of the month. Although we anxiously await that announcement, food and drink containers aren't the only means of BPA exposure. The Obama administration should begin, if it hasn't already, to contemplate a broader, inter-agency strategy to monitor and take action on BPA exposure.
(Matthew Madia 11/12/09; 1 comment)
This week, the U.S. Environmental Protection Agency began sending out test orders under its Endocrine Disruptor Screening Program (EDSP). EPA is asking chemical manufacturers to screen certain chemicals to determine whether they are endocrine disruptors – a term used to categorize any compound capable of causing certain reproductive and developmental abnormalities.
The first round of test orders covers seven pesticide chemicals, the names of which I would surely misspell if I attempted to recite them. You can find the list and more information here. The orders are being sent to all registrants for the pesticides in question. The first round of test orders were sent to 19 different firms, according to EPA’s website.
As expected, the test orders are loaded with references to Other Scientifically Relevant Information (OSRI) – existing studies that could limit or eliminate the need for industry to test their chemicals. Although that term appears in the law authorizing the EDSP, its prominence is a result of pressure from the White House Office of Management and Budget (OMB).
OMB added scads of language to EPA’s initial drafts that appears to encourage industry to submit OSRI. OMB’s edits have caused quite a stir in the public health crowd who say most currently available studies were not conducted with the goal of determining a chemical's effect on the endocrine system and did not study low-dose exposure. Endocrine disruptors are thought to disrupt hormone functions even at very low levels.
At this time, it is difficult to gauge the impact of OMB’s edits: if industry submits existing studies in tandem with fresh data generated through the EPA-developed testing protocols, no big deal; but if industry is able to submit studies in lieu of new testing, EPA may not get the data it needs to make critical decisions that protect the public from harmful substances. That back and forth, which could occur for multiple chemicals, will in part shape the EDSP and determine its effectiveness.
Ultimately, the decision rests with EPA. If the agency doesn’t believe OSRI submitted by industry is sufficient to determine the endocrine disrupting effects of these chemicals, it must push back and demand new data. If industry refuses, EPA has the authority to ban manufacturers from selling certain chemicals until they oblige.
The good news is that EPA appears ready to hold test order recipients to a tight schedule. Recipients have 90 days to tell EPA how they plan to find or generate the data. For those manufacturers submitting OSRI in lieu of new data, EPA writes, “You should be aware that if the Agency determines that the study is not acceptable, the Agency will require you to comply with this Order, normally without an extension of the required due date for submission of the data.” A progress report is due within one year, and the final responses are due within two years.
For more on the program and OMB’s role, see this article from the latest issue of The Watcher: “OMB Role in EPA Chemical Program Questioned.”
(Matthew Madia 10/30/09; 9 comments)